A survey by The Motley Fool found investors are confident that artificial intelligence companies will deliver strong returns over the long haul. Nvidia and Alphabet are positioned to benefit from AI ...

Data center projects in DeForest, Mount Pleasant, and Port Washington have raised understandable concerns from residents. It makes sense to be skeptical of big companies claiming job and revenue ...

Bubble Planet, the popular immersive experience at New Jersey’s American Dream Mall, is offering a limited-time 25% Black Friday discount, and tickets are selling quickly. Visitors can explore eight ...

On Wednesday evening, Nvidia, the chip firm at the center of the world, reported its quarterly earnings. It was by any measure a blowout for the world’s largest company: It made 65 percent more ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Theron Mohamed Every time Theron publishes a story, you’ll get an alert straight to your inbox!

As the world races to build artificial superintelligence, one maverick bioengineer is testing how much unprogrammed intelligence may already be lurking in our simplest algorithms to determine whether ...

Tarik Skubal, who's likely to win a second consecutive American League Cy Young Award, is entering a contract year in Detroit. Nick Cammett / Getty Images DETROIT — This offseason feels like a litmus ...

The stock market is running high. Too high, some analysts say. A number of Wall Street observers warn the stock market may have entered "bubble" territory. It’s an analogy to the overhyped markets of ...

SAN FRANCISCO, Oct 24 (Reuters) - IBM (IBM.N), opens new tab said on Friday it can run a key quantum computing error correction algorithm on commonly available chips ...

Palantir (PLTR) shows signs of bubble-like behavior, with aggressive growth expectations, high retail ownership, and a fervent narrative driving valuation. PLTR's valuation is extremely stretched, ...

A one-time gene therapy using a patient’s own stem cells has effectively cured a deadly immune disorder in 95% of treated children, offering a lasting, donor-free solution to ADA-SCID, known as the ...